-
17 August 2021
Global Fund and Tanzania Deepen Partnership to Fight COVID-19 and Accelerate End of HIV, TB and Malaria
The Global Fund and the Government of Tanzania are deepening their partnership with new investments to fight the COVID-19 crisis and accelerate the end of the epidemics of HIV, TB and malaria while building resilient and sustainable systems for healt... -
13 August 2021
Global Fund grants US$37 million to FIND to advance tuberculosis prevention and control in India
FIND, the global alliance for diagnostics, and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced that FIND has been awarded over US$37 million to ensure the inception and continuation of three projects dedicated to advancing tuberculo... -
14 July 2021
Global Fund Applauds Switzerland’s Leadership in The Global Fight Against COVID-19
The Global Fund to Fight AIDS, Tuberculosis and Malaria praised the decision by the Swiss Federal Council to make available CHF300 million to the Access to COVID-19 Tools (ACT) Accelerator – a ground-breaking global collaboration of leading public he... -
24 June 2021
Gavi And The Global Fund Sign Groundbreaking Agreement With International Federation Of Accountants To Support In-Country Financial Management
Global health leaders Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria have joined forces with the International Federation of Accountants (IFAC) to contribute to, and support, the implementation of robust accoun... -
21 May 2021
G20 Reaffirms Commitment to ACT-A to Fight COVID-19
G20 leaders and heads of international and regional organizations reaffirmed their commitment to fight pandemics and support the Access to COVID-19 Tools (ACT) Accelerator –a ground breaking collaboration of global partners to accelerate the developm... -
12 May 2021
Global Fund 45th Board Meeting Reports Continued Progress Despite COVID-19 Pandemic
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria overwhelmingly praised the continued progress of the Global Fund in the past year despite the challenges of the COVID-19 pandemic.